4th Quarter - Report — RK STRATEGIES, INC. for RECCE PHARMACEUTICALS LTD (2024)

Firm

RK STRATEGIES, INC.

Client

RECCE PHARMACEUTICALS LTD

Income

$20,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pandemic All Hazards Preparedness Act, S.3678 Pasteur Act, H.R.3932

Foreign entity interest: Recce Pharmaceuticals Inc is principally located in Sydney, Australia

Lobbyist	Covered position, as disclosed
RYAN KANE	—

Contacted: Defense Threat Reduction Agency (DTRA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3678 (118th), H.R. 3932 (118th)

Defense DEF

Anti-Infectives Legislation National Defense Authorization Act of 2024, S.2226

Foreign entity interest: Recce Pharmaceuticals Inc is principally located in Sydney, Australia

Lobbyist	Covered position, as disclosed
RYAN KANE	—

Contacted: SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Bills named: S. 2226 (118th)

Veterans VET

Anti-Infectives Legislation

Foreign entity interest: Recce Pharmaceuticals Inc is principally located in Sydney, Australia

Lobbyist	Covered position, as disclosed
RYAN KANE	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.